These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 27411455

  • 1. Determinants of Calcium Infusion Rate During Continuous Veno-venous Hemofiltration with Regional Citrate Anticoagulation in Critically Ill Patients with Acute Kidney Injury.
    Liu DL, Huang LF, Ma WL, Ding Q, Han Y, Zheng Y, Li WX.
    Chin Med J (Engl); 2016 Jul 20; 129(14):1682-7. PubMed ID: 27411455
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A continuous veno-venous hemofiltration protocol with anticoagulant citrate dextrose formula A and a calcium-containing replacement fluid.
    Ong SC, Wille KM, Speer R, Tolwani AJ.
    Int J Artif Organs; 2014 Jun 20; 37(6):499-502. PubMed ID: 24811309
    [Abstract] [Full Text] [Related]

  • 4. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
    Tiranathanagul K, Jearnsujitwimol O, Susantitaphong P, Kijkriengkraikul N, Leelahavanichkul A, Srisawat N, Praditpornsilpa K, Eiam-Ong S.
    Ther Apher Dial; 2011 Dec 20; 15(6):556-64. PubMed ID: 22107692
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation.
    Morabito S, Pistolesi V, Tritapepe L, Vitaliano E, Zeppilli L, Polistena F, Fiaccadori E, Pierucci A.
    Int J Artif Organs; 2013 Dec 20; 36(12):845-52. PubMed ID: 24362894
    [Abstract] [Full Text] [Related]

  • 7. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD).
    Mitchell A, Daul AE, Beiderlinden M, Schäfers RF, Heemann U, Kribben A, Peters J, Philipp T, Wenzel RR.
    Clin Nephrol; 2003 Feb 20; 59(2):106-14. PubMed ID: 12608553
    [Abstract] [Full Text] [Related]

  • 8. Low-dose citrate continuous veno-venous hemofiltration (CVVH) and acid-base balance.
    Naka T, Egi M, Bellomo R, Cole L, French C, Wan L, Fealy N, Baldwin I.
    Int J Artif Organs; 2005 Mar 20; 28(3):222-8. PubMed ID: 15818544
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.
    Schilder L, Nurmohamed SA, Bosch FH, Purmer IM, den Boer SS, Kleppe CG, Vervloet MG, Beishuizen A, Girbes AR, Ter Wee PM, Groeneveld AB, CASH study group.
    Crit Care; 2014 Aug 16; 18(4):472. PubMed ID: 25128022
    [Abstract] [Full Text] [Related]

  • 12. The plasma level and biomarker value of neutrophil gelatinase-associated lipocalin in critically ill patients with acute kidney injury are not affected by continuous venovenous hemofiltration and anticoagulation applied.
    Schilder L, Nurmohamed SA, ter Wee PM, Paauw NJ, Girbes AR, Beishuizen A, Beelen RH, Groeneveld AB.
    Crit Care; 2014 Apr 22; 18(2):R78. PubMed ID: 24755339
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Citrate anticoagulation for continuous venovenous hemofiltration.
    Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI, Dijksman LM, Zandstra DF.
    Crit Care Med; 2009 Feb 22; 37(2):545-52. PubMed ID: 19114912
    [Abstract] [Full Text] [Related]

  • 15. A pilot randomized controlled crossover study comparing regional heparinization to regional citrate anticoagulation for continuous venovenous hemofiltration.
    Fealy N, Baldwin I, Johnstone M, Egi M, Bellomo R.
    Int J Artif Organs; 2007 Apr 22; 30(4):301-7. PubMed ID: 17520566
    [Abstract] [Full Text] [Related]

  • 16. Citrate anticoagulation during CVVH in high risk bleeding patients.
    Cubattoli L, Teruzzi M, Cormio M, Lampati L, Pesenti A.
    Int J Artif Organs; 2007 Mar 22; 30(3):244-52. PubMed ID: 17417764
    [Abstract] [Full Text] [Related]

  • 17. Hyperlactatemia Predicts Citrate Intolerance With Regional Citrate Anticoagulation During Continuous Renal Replacement Therapy.
    Tan JN, Haroon SWP, Mukhopadhyay A, Lau T, Murali TM, Phua J, Tan ZY, Lee N, Chua HR.
    J Intensive Care Med; 2019 May 22; 34(5):418-425. PubMed ID: 28372501
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ionic homeostasis, acid-base balance and the risk of citrate accumulation in patients after cardiovascular surgery treated with continuous veno-venous haemofiltration with post-dilution regional citrate anticoagulation - An observational case-control study.
    Kośka A, Kowalik MM, Lango-Maziarz A, Karolak W, Jagielak D, Lango R.
    Acta Biochim Pol; 2021 Oct 29; 68(4):695-704. PubMed ID: 34714613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.